Medical News

RSS

Breakthrough reveals important human receptor structure that will aid drug development

Scientists at the MRC Laboratory of Molecular Biology (LMB) in Cambridge have obtained the first clear images of the proteins that relay vital messages to cells.

22 Oct 2007

New genetic and phenotypic data involved in autism released to researchers worldwide

The Autism Consortium, a group of researchers, clinicians and families dedicated to radically accelerating research and enhancing clinical care for autism, announced today that it has completed the first genome scan for Autism Spectrum Disorders (ASD) through its Autism Gene Discovery Project and has released the reference data set to a database that autism researchers around the world can use.

22 Oct 2007

Height may point to a biological basis for pedophilia

Height may point to a biological basis for pedophilia, according to new research released by the Centre for Addiction and Mental Health (CAMH).

22 Oct 2007

Smoking cessation programs should be tailored to age

A new study shows that obstacles to smoking cessation and motives for quitting smoking vary with age.

22 Oct 2007

Adenoscan patent lawsuits settled

Astellas Pharma Inc., King Pharmaceuticals, Inc. and Teva Pharmaceutical Industries Ltd. have announced that U.S. subsidiaries of Astellas, along with Item Development AB and King have executed settlement agreements with one of Teva's subsidiaries on lawsuits filed in the United States against Teva's subsidiaries regarding their submission of an abbreviated new drug application (ANDA) for a generic version of Adenoscan (adenosine injection), a pharmacologic stress agent.

22 Oct 2007

Longer-living, healthier mouse holds clues to human ageing

A study by scientists at UCL (University College London) shows that mice lacking the insulin receptor substrate (IRS)-1 are more resistant to ageing than normal mice.

22 Oct 2007

Six Sigma practices may provide significant benefits for hospitals

Although Six Sigma practices are widely used in the manufacturing industry, the performance improvement system also may provide significant benefits for hospitals, medical professionals, and patients.

22 Oct 2007

Prevalence of acne in adults 20 years and older

While acne is oftentimes as much a part of being a teenager as dating and Friday night football games, a new study examining the prevalence of acne in adults age 20 and older confirms that a significant proportion of adults continue to be plagued by acne well beyond the teenage years.

22 Oct 2007

Impact of income inequality on health in both rich and poor nations

A wide income gap between the most affluent and the worst off in society is closely associated with higher death rates worldwide, especially for younger adults, finds a study published on bmj.com as part of a global theme issue on poverty and human development.

22 Oct 2007

Comedy helps kids deal with pain for longer periods of time

Watching comedy shows helped children tolerate pain for longer periods of time, suggesting that humorous distraction could be used in clinical settings to help children and adolescents better handle painful procedures, according to a study which teamed UCLA's Jonsson Comprehensive Cancer Center with the nonprofit organization Rx Laughter.

22 Oct 2007

Syngenta licenses chromatin gene stacking technology

Syngenta Biotechnology Inc. has announced that it has entered into a research and commercial license agreement for Chromatin's proprietary gene stacking technology.

22 Oct 2007

The accumulation of sugar in neurons may explain the origin of several neurodegenerative diseases

A phenomenon considered healthy for cells, such as the accumulation of long chains of glucose (glycogen), which tissues store for energy purposes, is harmful for neurons.

22 Oct 2007

Discovery of two genes linked to a disabling form of arthritis called ankylosing spondylitis

An international team of researchers led by a Fred Hutchinson Cancer Research Center geneticist has discovered two genes linked to a disabling form of arthritis called ankylosing spondylitis, a painful and progressive disease in which some or all of the spine's vertebrae fuse together.

22 Oct 2007

Strong association between tattoos and hepatitis C virus infection

The connection between tattoos and hepatitis C virus (HCV) has long been suspected but never completely substantiated.

22 Oct 2007

Scientists find predisposition to bronchiolitis in some babies

Scientists have found that a large proportion of infants who suffer from bronchiolitis have an inherent pre-disposition to the disease.

22 Oct 2007

Scale back on weight obsession, urges obesity expert

"We need to change how we look at obesity, stop obsessing on weight and BMI and, above all, redefine the proper clinical use of weight loss drugs," says noted obesity expert Dr. Jean-Pierre Després, delivering the Heart and Stroke Foundation of Canada Lecture at the Canadian Cardiovascular Congress 2007.

22 Oct 2007

Sanofi Pasteur receives FDA approval of Menactra meningococcal vaccine for children

Sanofi Pasteur, the vaccines division of sanofi-aventis Group, announced today that the U.S. Food and Drug Administration (FDA) has granted licensure to expand the indication for its meningococcal conjugate vaccine, Menactra (Meningococcal [Groups A, C, Y and W-135] Polysaccharide Diphtheria Toxoid Conjugate Vaccine), to include children 2 years through 10 years of age.

22 Oct 2007

$6.8 million grant to help UTEP tackle Hispanic health disparities

The Hispanic Health Disparities Research Center at the University of Texas at El Paso has received a $6.8 million grant from the National Institutes of Health that will significantly advance the center's research in helping eliminate racial and ethnic health inequalities across the nation.

22 Oct 2007

FDA approves change in storage conditions for Humate-P

The U.S. Food and Drug Administration has approved a change in the storage conditions for Humate-P, a treatment for bleeding in certain patients with hemophilia A or von Willebrand Disease (vWD).

22 Oct 2007

Illumina launches MicroRNA assay for gene expression profiling

Illumina, Inc. today launched a MicroRNA Assay for Gene Expression profiling. Priced at $95 per sample, this assay is the only solution available to allow rapid and reproducible miRNA expression profiling at a price less than half that of other commercially available methods.

From Illumina, Inc. 22 Oct 2007